ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,881Medicare Part D Prescriptions Filled, Including Refills

Rank: 325 out of 2604

$513K Total Retail Price of All Prescriptions

Rank: 200 out of 2604

508 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,515 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 301 259 1 4
HYDROCODONE-ACETAMINOPHEN 193 110 S3 2 1
NAMENDA 187 177 3 37
DONEPEZIL HCL 160 160 4 28
CITALOPRAM HBR 156 141 5 18
SIMVASTATIN 117 109 6 2
METFORMIN HCL 117 98 6 7
MORPHINE SULFATE ER 111 27 S2 8 58
FUROSEMIDE 103 101 9 8
LISINOPRIL 100 81 10 3
POTASSIUM CHLORIDE 97 86 11 16
TRAMADOL HCL 95 76 12 15
GABAPENTIN 90 53 13 12
WARFARIN SODIUM 88 73 14 13
METHADONE HCL 86 15 S2 15 67
BUMETANIDE 82 82 16 70
AMLODIPINE BESYLATE 82 75 16 6
RAMIPRIL 79 75 18 111
OMEPRAZOLE 77 59 19 5
TAMSULOSIN HCL 75 57 20 30
METOPROLOL SUCCINATE 71 66 21 17
ZOLPIDEM TARTRATE 70 50 22 21
FENTANYL 68 37 S2 23 48
CARVEDILOL 65 57 24 26
DIVALPROEX SODIUM 64 58 25 81
SERTRALINE HCL 62 60 26 23
EXELON 62 59 26 150
METOPROLOL TARTRATE 59 52 28 9
RISPERIDONE 59 59 28 65
TRAZODONE HCL 58 41 30 46
LOSARTAN POTASSIUM 54 54 31 20
SPIRIVA 53 47 32 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 47 33 91
MIRTAZAPINE 52 48 33 52
PRAVASTATIN SODIUM 51 47 35 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 38 35 22
ESTRADIOL 50 48 R 37 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.